OABI OmniAb, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$4.87
· of 52w range
· above low
· to high
$1.3052w low
$5.4352w high
Market Cap (MRQ)
$708M
your badges
52W Range
$1–$5
Analyst Rating
BUY
Price Target
$8
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
OABI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.87
Market Cap (MRQ)
$708M
52W Range
$1–$5
OABI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | OABI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 2.7 | · | 1.7 | Undervalued | |
| Price / Tangible Book (MRQ) | 4.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | OABI | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.8 | · | 4.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
13.9%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.05 | $-0.12 | 59.2% |
| March 31, 2026 | May 7, 2026 | $-0.06 | $-0.10 | 41.2% |
| Dec. 31, 2025 | $-0.11 | $-0.09 | -21.8% | |
| Sept. 30, 2025 | $-0.14 | $-0.14 | 2.0% | |
| June 30, 2025 | $-0.15 | $-0.16 | 4.3% | |
| March 31, 2025 | $-0.17 | $-0.17 | -1.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $26M | |
| Receivables | $7M | |
| Inventory | $823.0K | |
| Prepaid Expense | $4M | |
| Other Current Assets | $1M | |
| Current Assets | $65M | |
| PP&E (Net) | $9M | |
| PP&E (Gross) | $29M | |
| Accum. Depreciation | $19M | |
| Goodwill | $84M | |
| Intangibles | $125M | |
| Other Non-current Assets | $912.0K | |
| Total Assets | $301M | |
| Accounts Payable | $2M | |
| Accrued Liabilities | $6M | |
| Current Liabilities | $16M | |
| Capital Leases | $16M | |
| Deferred Tax | $785.0K | |
| Other Non-current Liabilities | $78.0K | |
| Total Liabilities | $34M | |
| Common Stock | $14.0K | |
| Paid-in Capital | $433M | |
| Retained Earnings | $-166M | |
| AOCI | $12.0K | |
| Stockholders' Equity | $267M | |
| Liabilities + Equity | $301M | |
| Shares Outstanding | 144,308,383 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $13M | $14M | $4M | |
| R&D Expense | $10M | $10M | $13M | |
| SG&A Expense | $7M | $7M | $8M | |
| Operating Expenses | $20M | $22M | $23M | |
| Operating Income | $-7M | $-8M | $-19M | |
| Interest Income | $434.0K | $487.0K | $537.0K | |
| Other Non-op | $-9.0K | $77.0K | $1.0K | |
| Pretax Income | $-6M | $-7M | $-18M | |
| Income Tax | $-353.0K | $442.0K | $-106.0K | |
| Net Income | $-6M | $-8M | $-18M | |
| EPS (Basic) | $-0.05 | $-0.06 | $-0.17 | |
| EPS (Diluted) | $-0.05 | $-0.06 | $-0.17 | |
| Shares (Basic) | 128,795,000 | 128,245,000 | 105,622,000 | |
| Shares (Diluted) | 128,795,000 | 128,245,000 | 105,622,000 | |
| EBITDA | $-7M | $-8M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $24M | $29M | · | |
| Receivables | $10M | $13M | · | |
| Inventory | $1M | $920.0K | · | |
| Prepaid Expense | $4M | $3M | · | |
| Other Current Assets | $773.0K | $472.0K | · | |
| Current Assets | $66M | $65M | · | |
| PP&E (Net) | $8M | $9M | · | |
| PP&E (Gross) | $29M | $29M | · | |
| Accum. Depreciation | $20M | $20M | · | |
| Goodwill | $84M | $84M | · | |
| Intangibles | $116M | $119M | · | |
| Other Non-current Assets | $701.0K | $795.0K | · | |
| Total Assets | $290M | $294M | · | |
| Accounts Payable | $2M | $2M | · | |
| Accrued Liabilities | $4M | $4M | · | |
| Current Liabilities | $14M | $14M | · | |
| Capital Leases | $15M | $16M | · | |
| Deferred Tax | $882.0K | $1M | · | |
| Other Non-current Liabilities | $69.0K | $75.0K | · | |
| Total Liabilities | $30M | $31M | · | |
| Common Stock | $15.0K | $14.0K | · | |
| Paid-in Capital | $440M | $437M | · | |
| Retained Earnings | $-180M | $-174M | · | |
| AOCI | $-20.0K | $-2.0K | · | |
| Stockholders' Equity | $260M | $263M | · | |
| Liabilities + Equity | $290M | $294M | · | |
| Shares Outstanding | 145,390,398 | 144,783,813 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $4M | |
| Amort. of Intangibles | $3M | $6M | $3M | |
| Operating Cash Flow | $3M | $-5M | $-16M | |
| CapEx | $110.0K | $167.0K | $209.0K | |
| Investing Cash Flow | $-8M | $8M | $-878.0K | |
| Financing Cash Flow | $233.0K | $0 | $44.0K | |
| Net Change in Cash | $-5M | $4M | $-17M | |
| Free Cash Flow | · | $-5M | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Operating Margin | -49.5% | -54.3% | · | |
| Net Margin | -43.7% | -53.4% | · | |
| Pretax Margin | -46.3% | -50.4% | · | |
| EBITDA Margin | -49.5% | -54.3% | · | |
| ROA | -2.0% | -2.6% | · | |
| ROE | -2.2% | -2.9% | · | |
| ROIC | -2.4% | -3.2% | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 4.8 | 4.8 | · | |
| Quick Ratio | 2.5 | 3.1 | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 2.1 | 1.5 | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Book Value / Share | $1.79 | $1.81 | · | |
| Revenue / Share | $0.10 | $0.11 | · | |
| Cash Flow / Share | · | $-0.04 | · | |
| Cash / Share | $0.17 | $0.20 | · | |
| EPS (TTM) | $-0.36 | $-0.46 | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue TTM | $38M | $29M | · | |
| Net Income TTM | $-44M | $-54M | · | |
| Market Cap | $358M | $227M | · | |
| P/E | -6.8 | -3.4 | · | |
| P/S | 9.3 | 7.9 | · | |
| P/B | 1.4 | 0.9 | · | |
| P / Tangible Book | 5.9 | 3.8 | · | |
| P / Cash Flow | · | -46.3 | · | |
| Earnings Yield | -14.6% | -29.3% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 143 filers · $155.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
143
Value held
$155.4M
New positions
23
Exited positions
16
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 23 (-2 vs prior Q) | 16 (-4 vs prior Q) | 57 (+17 vs prior Q) | 31 (-7 vs prior Q) | +3.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Whitefort Capital Management, LP | $25,211,699 | 10,248,658 | 16.22% | Shares |
| BlackRock, Inc. | $21,887,827 | 8,897,490 | 14.08% | Shares |
| NOMURA HOLDINGS INC | $12,369,274 | 5,028,160 | 7.96% | Shares |
| VANGUARD GROUP INC | $10,406,615 | 5,625,197 | 6.69% | Shares |
| CADIAN CAPITAL MANAGEMENT, LP | $10,361,080 | 4,211,821 | 6.67% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $9,476,796 | 3,852,356 | 6.10% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $7,096,381 | 2,883,978 | 4.57% | Shares |
| RICE HALL JAMES & ASSOCIATES, LLC | $6,421,668 | 2,610,434 | 4.13% | Shares |
| PRIVATE MANAGEMENT GROUP INC | $5,768,134 | 2,344,770 | 3.71% | Shares |
| STATE STREET CORP | $5,248,531 | 2,133,549 | 3.38% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $3,105,584 | 1,262,099 | 2.00% | Shares |
| TOWERVIEW LLC | $2,902,800 | 1,180,000 | 1.87% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,411,823 | 980,416 | 1.55% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,378,517 | 966,877 | 1.53% | Shares |
| NORTHERN TRUST CORP | $2,332,803 | 948,294 | 1.50% | Shares |
| ADAR1 Capital Management, LLC | $2,330,634 | 947,412 | 1.50% | Shares |
| ISTHMUS PARTNERS, LLC | $1,976,433 | 803,428 | 1.27% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,865,812 | 758,460 | 1.20% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,617,283 | 657,432 | 1.04% | Shares |
| Nuveen, LLC | $1,581,315 | 642,811 | 1.02% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,476,861 | 600,350 | 0.95% | Shares |
| D. E. Shaw & Co., Inc. | $1,376,134 | 559,404 | 0.89% | Shares |
| MACKENZIE FINANCIAL CORP | $1,203,270 | 489,134 | 0.77% | Shares |
| GOLDMAN SACHS GROUP INC | $946,049 | 384,573 | 0.61% | Shares |
| MORGAN STANLEY | $913,905 | 371,506 | 0.59% | Shares |
| MILLENNIUM MANAGEMENT LLC | $864,306 | 474,159 | 0.56% | Shares |
| Kent Lake PR LLC | $800,000 | 500,000 | 0.51% | Shares |
| Bank of New York Mellon Corp | $783,279 | 318,406 | 0.50% | Shares |
| TLS Advisors LLC | $542,885 | 220,685 | 0.35% | Shares |
| FMR LLC | $491,552 | 199,818 | 0.32% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $489,294 | 198,900 | 0.31% | Shares |
| Arbiter Partners Capital Management LLC | $473,759 | 192,585 | 0.30% | Shares |
| RHUMBLINE ADVISERS | $423,003 | 171,957 | 0.27% | Shares |
| Palumbo Wealth Management LLC | $398,459 | 161,975 | 0.26% | Shares |
| Invesco Ltd. | $396,986 | 161,376 | 0.26% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $392,668 | 159,621 | 0.25% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $387,981 | 157,716 | 0.25% | Shares |
| BANK OF AMERICA CORP /DE/ | $367,753 | 149,493 | 0.24% | Shares |
| TWO SIGMA ADVISERS, LP | $365,431 | 197,530 | 0.24% | Shares |
| Walleye Capital LLC | $355,290 | 144,427 | 0.23% | Shares |
| Cornerstone Capital, Inc. | $350,024 | 142,286 | 0.23% | Shares |
| JPMORGAN CHASE & CO | $275,115 | 107,049 | 0.18% | Shares |
| DEUTSCHE BANK AG\ | $248,071 | 100,842 | 0.16% | Shares |
| WELLS FARGO & COMPANY/MN | $246,563 | 100,229 | 0.16% | Shares |
| ALLIANCEBERNSTEIN L.P. | $244,907 | 155,992 | 0.16% | Shares |
| Northeast Financial Consultants Inc | $193,134 | 110,996 | 0.12% | Shares |
| AMERICAN CENTURY COMPANIES INC | $184,704 | 75,083 | 0.12% | Shares |
| XTX Topco Ltd | $181,811 | 73,907 | 0.12% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $177,999 | 72,357 | 0.11% | Shares |
| MetLife Investment Management, LLC | $161,730 | 65,744 | 0.10% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Avista Capital Partners V, L.P., Avista Capital Partners (Offshore) V, L.P., Avista Capital Partners V GP, L.P., Avista Capital Managing Member V, LLC, Thompson Dean, David Burgstahler | July 2, 2024 | · | Initial filing | · | SEC |
| Avista Acquisition LP II, Avista Acquisition GP LLC II, Avista Capital Partners V, L.P., Avista Capital Partners (Offshore) V, L.P., Avista Capital Partners V GP, L.P., Avista Capital Managing Member V, LLC, Thompson Dean, David Burgstahler ×2 filings | Dec. 13, 2022 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 3 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Matthew W Foehr | President and CEO | Feb. 18, 2025 A | 3,779,160 | 0 | 0 | $0 |
| Kurt A Gustafson | Executive VP, Finance and CFO | Feb. 18, 2026 A | 268,851 | 0 | 2 | $-62,792 |
| Amechi Ekeke Nwachuku | Chief Operating Officer | Aug. 1, 2026 A | · | 0 | 0 | $0 |
| Steven C. Crouse | Director | April 21, 2026 M | 13,333 | 0 | 0 | $0 |
| Philip J Gotwals | Director | April 21, 2026 M | 13,333 | 0 | 0 | $0 |
| Jennifer R. Cochran | Director | June 17, 2025 A | 165,274 | 0 | 0 | $0 |
| Steven Love | Director | June 17, 2025 A | 58,333 | 0 | 0 | $0 |
| John L Higgins | Director | March 21, 2025 P | 2,766,887 | 0 | 0 | $0 |
| Carolyn R Bertozzi | Director | Nov. 1, 2024 M | 55,539 | 0 | 0 | $0 |
| Sarah Boyce | Director | June 18, 2024 A | 68,381 | 0 | 0 | $0 |
| Sunil Patel | Director | June 23, 2023 A | 224,265 | 0 | 0 | $0 |
| Charles S Berkman | · | Feb. 18, 2026 A | 392,700 | 0 | 2 | $-32,307 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 23 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.10% | 373,741 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.05% | 10,345 SH | Oct. 2, 2026 | Daily |
| IBB · iShares Trust | 0.03% | 904,033 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 98,249 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 2,793,672 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 71,118 SH | Oct. 2, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 6,660 SH | Oct. 1, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 632,797 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 52,524 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 8,300 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 10,686 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 13,200 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 44,303 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 130,992 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 19,649 SH | Sept. 4, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 22,797 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 74,974 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 14,264 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,390,197 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,379,734 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,335 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 239,035 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 1,014,939 SH | Sept. 11, 2026 | Daily |
OABI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$9.00
+84.8%
4 30.8%
Strong Buy
8 61.5%
Buy
1 7.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-03Mean target $8.40 +72.5%
← Below all targets
Current price $4.87
Low$5.00
Mean$8.40
High$11.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OABI | · | · | · | · | · | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| QSI | · | · | · | · | · | · |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026